{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T12:26:14Z","timestamp":1768307174482,"version":"3.49.0"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:p>\n                    We developed a nuclear grading system for melanoma, the UNC Chapel Hill Method, akin to McGovern\u2019s 1970 classification, to evaluate its correlation with disease progression and adverse histologic features, including thickness, mitotic rate, and ulceration. This retrospective study analyzed 544 melanomas diagnosed from 2020 to 2023, with a median follow-up of 411 days; 89 patients experienced progression, and 22 died of disease. A dermatopathologist assigned nuclear grades based on nuclear size, membrane contour, nucleolar features, and chromatin arrangement. Grade 1 resembled nevus nuclei, Grade 3 exhibited marked nuclear abnormalities, and Grade 2 was intermediate. Kaplan-Meier survival analysis demonstrated significantly worse progression-free survival for Grade 3 lesions compared with grades 1 and 2 (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt;0.003). Statistical analyses (Student\n                    <jats:italic toggle=\"yes\">t<\/jats:italic>\n                    test, \u03c7\n                    <jats:sup>2<\/jats:sup>\n                    , and Kruskal-Wallis) revealed that grade 3 melanomas were associated with increased age, Breslow thickness, mitotic rate, ulceration, advanced AJCC stage, and mortality (each\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt;0.05). In a univariate Cox model, grade 2 (HR: 1.7; 95% CI: 0.7-4.0) and grade 3 (HR: 3.6; 95% CI: 1.5-8.4) lesions had an increased risk of progression relative to grade 1. After adjusting for covariates, hazard ratios were attenuated for grade 2 (HR: 1.2; 95% CI: 0.5-2.9) and grade 3 (HR: 1.7; 95% CI: 0.7-4.2). These findings show nuclear grade is associated with melanoma progression, but increased statistical power with longer follow-up and additional cases are needed to assess its independent prognostic value.\n                  <\/jats:p>","DOI":"10.1097\/pas.0000000000002490","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T06:00:10Z","timestamp":1768284010000},"page":"227-231","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic Value of a Novel Nuclear Grading of Cutaneous Melanoma"],"prefix":"10.1097","volume":"50","author":[{"given":"Sarah G.","family":"McAlpine","sequence":"first","affiliation":[{"name":"University of North Carolina at Chapel Hill"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shantanu","family":"Srivatsa","sequence":"additional","affiliation":[{"name":"University of North Carolina at Chapel Hill"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paige C.","family":"Jones","sequence":"additional","affiliation":[{"name":"Department of Surgery, Division of Surgical Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle","family":"Davari","sequence":"additional","affiliation":[{"name":"Department of Dermatology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivian","family":"Lei","sequence":"additional","affiliation":[{"name":"Department of Dermatology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Melendez-Gonzalez","sequence":"additional","affiliation":[{"name":"Department of Dermatology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn","family":"Conlon","sequence":"additional","affiliation":[{"name":"Department of Surgery, Division of Surgical Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahlet","family":"Gebrekidan","sequence":"additional","affiliation":[{"name":"Department of Surgery, Division of Surgical Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stergios J.","family":"Moschos","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Oncology, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, NC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frances A.","family":"Collichio","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Oncology, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, NC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Sorah","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Oncology, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, NC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon N.","family":"Edmiston","sequence":"additional","affiliation":[{"name":"Department of Dermatology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen","family":"Conway","sequence":"additional","affiliation":[{"name":"Department of Dermatology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jayson","family":"Miedema","sequence":"additional","affiliation":[{"name":"Department of Dermatology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David W.","family":"Ollila","sequence":"additional","affiliation":[{"name":"Department of Surgery, Division of Surgical Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy E.","family":"Thomas","sequence":"additional","affiliation":[{"name":"Department of Dermatology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul B.","family":"Googe","sequence":"additional","affiliation":[{"name":"Department of Dermatology"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"key":"R1-20260113","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0022-5347(17)36518-7","article-title":"Correlation of prostate cancer nuclear deoxyribonucleic acid, size, shape and Gleason grade with pathological stage at radical prostatectomy","volume":"148","author":"Epstein","year":"1992","journal-title":"J Urol"},{"key":"R2-20260113","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1046\/j.1365-2559.1999.035005393.x","article-title":"DCIS grading schemes and clinical implications","volume":"35","author":"Shoker","year":"1999","journal-title":"Histopathology"},{"key":"R3-20260113","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1148\/radiol.211425","article-title":"US, mammography, and histopathologic evaluation to identify low nuclear grade ductal carcinoma in situ","volume":"303","author":"Lee","year":"2022","journal-title":"Radiology"},{"key":"R4-20260113","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF02967488","article-title":"Correlation between nuclear grade and biological prognostic variables in invasive breast cancer","volume":"8","author":"Yang","year":"2001","journal-title":"Breast Cancer"},{"key":"R5-20260113","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/his.15065","article-title":"Updates on grading mesothelioma","volume":"84","author":"Schulte","year":"2024","journal-title":"Histopathology"},{"key":"R6-20260113","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/cncr.22463","article-title":"Prognostic ability of simplified nuclear grading of renal cell carcinoma","volume":"109","author":"Rioux-Leclercq","year":"2007","journal-title":"Cancer"},{"key":"R7-20260113","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2559.1991.tb00229.x","article-title":"Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up","volume":"19","author":"Elston","year":"1991","journal-title":"Histopathology"},{"key":"R8-20260113","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/00313027009077330","article-title":"The classification of melanoma and its relationship with prognosis","volume":"2","author":"McGovern","year":"1970","journal-title":"Pathology"},{"key":"R9-20260113","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1080\/14737140.2018.1489246","article-title":"The eighth edition American Joint Committee on Cancer (AJCC) melanoma staging system: implications for melanoma treatment and care","volume":"18","author":"Keung","year":"2018","journal-title":"Expert Rev Anticancer Ther"},{"key":"R10-20260113","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s40291-018-0357-5","article-title":"Systematic review and meta-analysis of the prognostic significance of miRNAs in melanoma patients","volume":"22","author":"Sabarimurugan","year":"2018","journal-title":"Mol Diagn Ther"},{"key":"R11-20260113","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s40257-024-00910-y","article-title":"Prognostic biomarkers in evolving melanoma immunotherapy","volume":"26","author":"Reschke","year":"2025","journal-title":"Am J Clin Dermatol"},{"key":"R13-20260113","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1158\/0008-5472.CAN-12-0928","article-title":"Chromothripsis and focal copy number alterations determine poor outcome in malignant melanoma","volume":"73","author":"Hirsch","year":"2013","journal-title":"Cancer Res"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002490","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T06:00:12Z","timestamp":1768284012000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002490"}},"subtitle":["The UNC Chapel Hill Method"],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002490","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"value":"0147-5185","type":"print"},{"value":"1532-0979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]}}}